Contact us Press Pack
Cannabiz Logo
Book a Pass Sponsor
Book a Pass Sponsor
Sponsor
Register
Agenda
Speakers

ABOUT

Following the successful launch of Medical Cannabiz World in 2019, which attracted more than 1,500 delegates, SiGMA Group has decided to further its offering in the healthcare space through its latest vertical, Med Tech World. The second edition of Med-Cann World will take place virtually, in tandem with the recently launched vertical, Med-Tech World, on 20 & 21 October 2020.

MED CANN WORLD

Launched in 2019, Med Cann World offers a 360 degree look at the global medical cannabis industry, offering expert-led insight into newly emerging markets, research and development in an evolving regulatory landscape, as well as a personalised, patient-focussed perspective on medical policies and care.

MED TECH WORLD

The inaugural edition of Med Tech World highlights leading innovations in emerging tech for the European medical ecosystem. Leading experts will address the opportunities and challenges the industry faces – debating hot-button issues revolutionising the face of medicine and patient care. From deep learning and surgical robotics, to bio-printing and augmented reality, as well as regulatory issues such as patents and clinical trials, Med Tech World brings medicine into the future.
Explore Agenda.



Supported by

Speakers

Want to get involved as one of the speakers for either Medical Cannabiz World or Med Tech World? Reach out to Elisa.

Hon. Chris
Fearne

Deputy Prime Minister and Minister for Health - Government of Malta

Prof Charmaine
Gauci

Superintendent of Public Health, Ministry for Health; Associate Professor, University of Malta

Hon. Deo
Debattista

Parliamentary Secretary for Consumer Protection, Medicines Authority and Public Cleansing

Hon. Silvio
Schembri

Minister for the Economy, Investment and Small Business - Government of Malta

Prof Anthony
Serracino Inglott

Professor - The Department of Pharmacy of the University of Malta

Dr Christopher
Barbara

Chairperson, Department of Pathology, Mater Dei Hospital

Halima
Al-Hatimy

Founder & President - FemCare Community Health Initiative

Dr Karen
Korn

Executive Director & CEO – Leaf Medic

Dr Aziz
Chraibi

Director Engineering and Compliance - PBE Expert

Gagandeep
Singh

Founder - GDS Consulting

Steven
Laviolette

Professor and Neuroscientist - Schulich School of Medicine & Dentistry at Western University

Sherry
Boodram

CEO & Co-founder - CannDelta

Stephen
Oliver

Co-founder - The Canna Consultants

Dr. Gege
Gatt

CEO - EBO

Omar
Khan

National Cannabis Sector Lead, Hill+Knowlton Strategies

Daniel
Sax

Founder & CEO - Sensi Properties

Bryan
Mathias

Director of Business Development - SYNEO

Daniel
Yazbeck

Founder - Yazbeck Investment Group

Lorandt
Foelkel

Global Business Manager & FAE - Würth Elektronik eiSos

Rachel
Zedeck

Farmer & Investor

Brad
Hofman

Business Consultant - bizfincanvas.com

Guillermo
Trejo Negrete

Founder and CEO - WKLASSCANADA

Matthew
Nordgren

Founder/Managing Partner - Arcadian Capital

Oliver
Bisazza

Director Regulations & Industrial Policy - MedTech Europe

Roei
Zerahia

Co-Founder and Former CEO - Canndoc-Pharma; Senior staff member - Shenkar College

Ofer
Spottheim

CEO - CannaDu

Lucas
McCann

Co-founder and Chief Scientific Officer - CannDelta Inc

Stuart
Lambie

Secretary General - Medicinal Cannabis Europe

Chen
Porat

Co-founder - Nova Plasma Ltd

Nigel
Job

CEO - Remtec Talent Management Ltd

Eyal
Mishori

Head of Global Business Development - Breath Of Life Pharma

Anne Katrin
Schlag

Head of Research - DrugScience

Hannah
Deacon

Medical Cannabis Campaigner

David
Berg

President & CTO - Strainprint Technologies Ltd

Prof Dr Ing
Sandro Wartzack

Head of chair ENGINEERING DESIGN - FAU Erlangen-Nürnberg

Sandra
Carrillo

Clinical Professor - Scientific program of Cannabinoid Medicine, University of Panama

Robert
Galarza

CEO - TruTrace Technologies, Inc.

Dominnique
Karetsos

CEO & Co-founder - The Healthy Pleasure Group

Sigal
Ofek

Owner - Agromega Projects

Ronen
Shemesh

CSO & Founder - FertiProt

Mike
Karim

CEO - Oxford Endovascular Ltd

Ivan
Ross Vrána

Vice President – Government Relations and Business Development Eve & Co

Amelia
Middlemiss

Director Project - Twenty21

Alix
Hadley

CEO - C.R.A.F.T. Cannabis Inc.; CCO - TYCH B.V.

Jacqueline
Poitras

Founder - MAMAKA

Carola
Pérez

Founder - Dosemociones

Dr Joseph
Rosado

CEO & Physician - International Medical Consultants, Inc.

Dr Lucio
Fumi, MD

CEO - Wyfold Medical Consultancy

Daniel
Teo

Managing Partner - Hunniwell Lake Ventures

Dr Mark
A. Braunstein

CEO - Reconscious Medical

Dmitrij
Velikan

Director of Sales EMEA - machinesolutions

Dr Francis
Scanlan

Managing Director & Founder - Cloud 9 Switzerland LLC

Dr Rachel
Knox

Co-founder - Doctors Knox, Inc.

Dr Deo
Falzon

Associate - Fenech & Fenech Advocates

Deepak
Pareek

CEO & Founder, DigiAgri Technologies

Liz
Ashall-Payne

CEO - ORCHA

Guggi
Kofod

CEO - Rel8 Aps

Leah
Heise

Chief Administrative Officer - Ascend Wellness Holdings, LLC

Damon
Booth

Founder and CMO - Melabis

Quentin
Galland

Account Director - Hague Corporate Affairs

Alex
Revich

Director of Partner Development - Hybrid Pharm

Prof Victor
Grech

Clinical Advisor - Tabib.mt; Leading Pediatrician

Prof Pierre
Schembri-Wismayer MD PhD

Associate Professor - Anatomy Department, University of Malta

Ing Donald
Dalli

PhD Student - MALTAHIP project, University of Malta

Stephen
Murphy

Managing Director - Prohibition Partners

Thanos
Rammos

Attorney and Partner / Specialist Lawyer for IT Law - Taylor Wessing

Alan
Platt

COO - CyberHive

Mareike
Seesselberg

Senior Consultant - CHINABRAND IP CONSULTING GmbH

Jenn
Larry

President - CBD Strategy Group

Dr Malcolm
Falzon

Partner - Camilleri Preziosi

Stephen
Verbeek

President & CEO - Hello Cannabis

Nikhil
Sadhwani

Managing Partner - Kaviar Consulting, LLC

Dr Nupur
Kohli

Director - NIIS Healthcare

Aaron
Green

Managing Partner - Iridium Enterprises, LLC

Dr. Simon
J. Sonntag

CEO&Co-Founder - Virtonomy

Giovanni
Lauricella

Vice President, MedTech - The Mullings Group

Julian
Fearne

Senior Pharmacist - Malta Medicines Authority

Karen
Farrugia

Senior Pharmacist - Malta Medicines Authority

Valentino
Megale, Ph.D.

CEO - Softcare Studios

JP
Fabri

Co-Founding Partner - Seed Consultancy

Prof Ann
Lloyd Keen

Chair - CPASS; Co-Founder - CPASS’ Nurses Arm

Thomas
Grima

Medical Scientific Liason - Pharma.MT

Elliot
Turrini

CEO - Practical Cyber

Dr Matthew
Fenech

Medical Safety Lead - Ada Health

Sylvia
Kim

Managing Director - Koa Venture Fund

Andrew
Agius

Medical Director - The Pain Clinic

Michael
Psaila Debono

Project Unit Lead - Tabib.mt

Dr Ryan
Grech

Co-Founder - Digital Health Malta

Jeff
Rynbrandt

President and CEO - MediCool Technologies, Inc.

Brennan
Spiegel, MD, MSHS

Professor of Medicine and Public Health - Cedars-Sinai

Kenneth
Terribile

Senior Technical Sales Engineer - Melita

Prof. Russell
Smith

Director of the Centre for Entrepreneurship and Business Incubation - University of Malta

Dr Stefan
Buttigieg

Co-Founder - Digital Health Malta

Dr Amy
Tanti

Head of Quality Assurance and Pharmacovigilance - Materia Malta Operating Ltd.; Co-founder & Director - All Life Sciences

Dr Dylan
Attard

Co-Founder - Digital Health Malta

Prof Philip
Farrugia

Associate Professor - University of Malta

Dr. Conrad
Attard

Deputy Dean Faculty of ICT, Researcher, and Lecturer - University of Malta; Chair - IEEE Malta

Dr Moran
Grinberg

CEO - Medikana Inc.

Golan
Bitton

CEO & CO-Founder - UNIVO Pharmaceuticals

Call for Speakers

Agenda

Two days, two conferences! On the 20-21 of October 2020:

  • Med Cann World: October 20th  from 10:00 – 17:00 CET
  • Med Tech World: October 21st from 10:00 – 17:00 CET

Med-Cann

Med-Tech

* All our time are in Central European Time (CET)
20th October Med Cann 10:00 - 17:00*

INTRODUCTION

10:00 - 10:05

Introduction of Med Cann World

Hon. Silvio Schembri

Minister for the Economy, Investment and Small Business - Government of Malta

POLICY MAKING & REGULATION

10:05 - 10:25

WHO and its impact on national policies International organisations such as the World Health Organisation are becoming increasingly vocal on the application of medical cannabis. How is this impacting policymakers at state-level across different continents?

Damon Booth

Founder and CMO - Melabis

Sherry Boodram

CEO & Co-founder - CannDelta

Ivan Ross Vrána

Vice President – Government Relations and Business Development Eve & Co
10:25 - 10:40

Israel: Export regulations and global business developmentHow Israel is getting ready for the global export of medical cannabis products grown and cultivated locally.

Roei Zerahia

Co-Founder and Former CEO - Canndoc-Pharma; Senior staff member - Shenkar College

Eyal Mishori

Head of Global Business Development - Breath Of Life Pharma
10:40 - 11:05

Prohibitive licensing fees Companies are worried that the cost of setting up a medical cannabis business are prohibitive to launching products that are affordable for the patient. How are European markets handling this?

Jenn Larry

President - CBD Strategy Group

Rachel Zedeck

Farmer & Investor

Stephen Verbeek

President & CEO - Hello Cannabis

MEDICAL CANNABIS IN THE EU: WHERE DO WE STAND?

11:05 - 11:15

The need of regulating cannabis for medicinal use

Hon. Deo Debattista

Parliamentary Secretary for Consumer Protection, Medicines Authority and Public Cleansing
11:15 - 11:20

Harmonising EU Regulations: a Multi-stakeholder ApproachRegulation of medicinal cannabis applications varies greatly across the European Union. Only by bringing the voices of all stakeholder groups together can we hope to pave the way towards a harmonized approach across Europe, resulting clear regulation for industry and patient access to consistent, high quality medicines.

Stuart Lambie

Secretary General - Medicinal Cannabis Europe
11:20 - 11:30

Is CBD the new demon drug? The EU recently made a statement that CBD is to be considered a narcotic. Context and implications of this statement especially in regard to the upcoming vote of the UN Commission of Narcotic Drugs in December 2020.

Dr Francis Scanlan

Managing Director & Founder - Cloud 9 Switzerland LLC

PATIENT TESTIMONY

11:30 - 11:55

Patients’ perspectives: from individual struggles to collaborative solutions Starting from how patients’ individual struggles drove them to take action and advocate for their rights to access high-quality and safe medicinal cannabis, we will discuss why cross-sectorial collaboration is the most effective way to support them and push for an impactful change.

Andrew Agius

Medical Director - The Pain Clinic

Jacqueline Poitras

Founder - MAMAKA

Carola Pérez

Founder - Dosemociones

Prof Ann Lloyd Keen

Chair - CPASS; Co-Founder - CPASS’ Nurses Arm
11:55 - 12:05

Paediatric care Use cases in children with different illnesses.

Dr Joseph Rosado

CEO & Physician - International Medical Consultants, Inc.
12:05 - 12:30

Cannabis education: a public approach What sort of public awareness campaigns are needed to de-stigmatise medical cannabis and give appropriate information on the available options?

Thomas Grima

Medical Scientific Liason - Pharma.MT

Dr Karen Korn

Executive Director & CEO – Leaf Medic

Lucas McCann

Co-founder and Chief Scientific Officer - CannDelta Inc

Guillermo Trejo Negrete

Founder and CEO - WKLASSCANADA

MEDICAL RESEARCH

12:30 - 12:40

Cannabis Health Equity What is cannabis health equity, and what steps can we take to achieve it?

Dr Rachel Knox

Co-founder - Doctors Knox, Inc.
12:40 - 13:00

The ongoing debate about cancer treatment Leading oncologists and cannabis educators discuss the research on treating various cancers with medical cannabis.

Dr Francis Scanlan

Managing Director & Founder - Cloud 9 Switzerland LLC

Ronen Shemesh

CSO & Founder - FertiProt

Alex Revich

Director of Partner Development - Hybrid Pharm
13:00 - 13:10

Designing Safer Cannabinoid Pharmacotherapies Cannabis use is associated with major psychiatric side effects in some individuals. In this presentation, evidence will be described regarding how modifications to THC or CBD formulations can both reduce unwanted side-effects and in some cases, improve the efficacy of cannabis-derived medications.

Steven Laviolette

Professor and Neuroscientist - Schulich School of Medicine & Dentistry at Western University
13:10 - 13:30

Cannabis for the treatment of Neurologic Disorders: an update Treating patients with neurologic disorders with medical cannabis. How do the clinical trials compare to the anecdotal evidence?

Sandra Carrillo

Clinical Professor - Scientific program of Cannabinoid Medicine, University of Panama

Amelia Middlemiss

Director Project - Twenty21

Anne Katrin Schlag

Head of Research - DrugScience

Jeremy Micallef

Reporter - SiGMA

AFTERNOON INTRODUCTION

13:45 - 13:55

Quality aspects of medical cannabis-based products

Prof Anthony Serracino Inglott

Professor - The Department of Pharmacy of the University of Malta

BUSINESS CONSIDERATIONS

13:55 - 14:20

Moving from the farm to pharma How we are moving from farmers in order to become pharmaceutical products. Focus EU legislation

Roei Zerahia

Co-Founder and Former CEO - Canndoc-Pharma; Senior staff member - Shenkar College

Daniel Torres Gonçalves

Managing Partner - K.LEX

Quentin Galland

Account Director - Hague Corporate Affairs
14:20 - 14:30

Canada: Supply and demand What can European markets learn from Canada for the accurate forecasting of demand in this new industry?

Daniel Yazbeck

Founder - Yazbeck Investment Group
14:30 - 14:55

Educating medical professionals What sort of qualifications should medical professionals obtain before prescribing cannabis based treatments?

Thomas Grima

Medical Scientific Liason - Pharma.MT

Jacquie Cohen Roth

Founder & CEO - Tea Pad, LLC & CannabizMD

Hannah Deacon

Medical Cannabis Campaigner

David Berg

President & CTO - Strainprint Technologies Ltd
14:55 - 15:15

The future is female How women are leading disruptive change in the medical cannabis industry

Dr Amy Tanti

Head of Quality Assurance and Pharmacovigilance - Materia Malta Operating Ltd.; Co-founder & Director - All Life Sciences

Alix Hadley

CEO - C.R.A.F.T. Cannabis Inc.; CCO - TYCH B.V.

Leah Heise

Chief Administrative Officer - Ascend Wellness Holdings, LLC

Halima Al-Hatimy

Founder & President - FemCare Community Health Initiative

INVESTMENT

15:15 - 15:35

Cannabis Industry Outlook Talking about the Global Legal Marijuana Market Share with an insight into 2 major markets (the US and Canada). Reviewing some of the companies operating in these markets and seeing where they stand in the current market and what has been affecting them.

Gagandeep Singh

Founder - GDS Consulting
15:35 - 15:50

Raising funds from traditional sources How to attract investment and loans in a sector that's not only new, but also has negative connotations associated with it. Focusing on where we were, where we are, and where we're going..

JP Fabri

Co-Founding Partner - Seed Consultancy

Brad Hofman

Business Consultant - bizfincanvas.com

Daniel Sax

Founder & CEO - Sensi Properties

Ofer Spottheim

CEO - CannaDu
15:50 - 16:00

Strategies for risk mitigation Investment firms have highlighted several risk factors in investing in the Asia medical cannabis industry. How are these to be reduced?

Matthew Nordgren

Founder/Managing Partner - Arcadian Capital
16:00 - 16:10

Opportunities and the barriers to investment in the European Space The proceeds of crime, money laundering and strategies for lawful investment.

Stephen Oliver

Co-founder - The Canna Consultants

GROW OPERATIONS

16:10 - 16:30

Good manufacturing practices What are the best practices for the layout and design of manufacturing?

Dr Aziz Chraibi

Director Engineering and Compliance - PBE Expert

Chen Porat

Co-founder - Nova Plasma Ltd

Sigal Ofek

Owner - Agromega Projects

Jeremy Micallef

Reporter - SiGMA
16:30 - 16:50

Bridging the knowledge gap How data and information is pushing forward regulatory change, helping operators unlock the commercial potential of cannabis and supporting the connection between the doctor, the patient and the suppliers.

Stephen Murphy

Managing Director - Prohibition Partners

Dr Mark A. Braunstein

CEO - Reconscious Medical

Dr Moran Grinberg

CEO - Medikana Inc.

Jeremy Micallef

Reporter - SiGMA
16:50 - 17:15

Traceability: how blockchain and cannabis are a match made in heavenHow will blockchain disrupt this sector and transform it into a more lucrative and competitive endeavour?

JP Fabri

Co-Founding Partner - Seed Consultancy

Robert Galarza

CEO - TruTrace Technologies, Inc.

Deepak Pareek

CEO & Founder, DigiAgri Technologies
* All our time are in Central European Time (CET)
21st October Med Tech 10:00 - 17:00*

INTRODUCTION

10:00 - 10:05

Introduction of inaugural edition of MedTech World

Hon. Chris Fearne

Deputy Prime Minister and Minister for Health - Government of Malta

REGULATION & BUSINESS

10:05 - 10:25

Medical device clinical trials The crossroads between innovation and implementation.

Dr Lucio Fumi, MD

CEO - Wyfold Medical Consultancy

Guggi Kofod

CEO - Rel8 Aps

Jeremy Micallef

Reporter - SiGMA
10:25 - 10:35

Medical Device Regulation and Notified Bodies What are the challenges for the implementation of this EU-wide regulation? What's the future for UK-based Notified Bodies post-Brexit?

Oliver Bisazza

Director Regulations & Industrial Policy - MedTech Europe
10:35 - 11:00

The Impact of COVID-19 on the Medical Device Industry As of end September 2020 over 34 million people have been confirmed to be infected with the SARS-CoV-2 coronavirus. Healthcare systems are being overwhelmed, and the field of medical devices is no exception. An impact has been felt throughout the supply chain, from manufacturing to procurement and distribution and the medical device industry is finding it challenging to make informed decisions about supply chains, and regulatory obligations in the midst of uncertainty.

Julian Fearne

Senior Pharmacist - Malta Medicines Authority

Prof Anthony Serracino Inglott

Professor - The Department of Pharmacy of the University of Malta

Dr Christopher Barbara

Chairperson, Department of Pathology, Mater Dei Hospital

Karen Farrugia

Senior Pharmacist - Malta Medicines Authority

PATIENT FOCUSED TECH

11:00 - 11:20

Telemedicine The pros and cons of remote diagnosis.

Michael Psaila Debono

Project Unit Lead - Tabib.mt

Prof Victor Grech

Clinical Advisor - Tabib.mt; Leading Pediatrician

Dr Malcolm Falzon

Partner - Camilleri Preziosi
11:20 - 11:35

Precision medicine Using data and analytics to customise and optimise treatment.

Prof Dr Ing Sandro Wartzack

Head of chair ENGINEERING DESIGN - FAU Erlangen-Nürnberg

MED TECH INNOVATIONS

11:35 - 12:00

Artificial intelligenceConversational AI in healthcare.

Dr. Gege Gatt

CEO - EBO

Dr Nupur Kohli

Director - NIIS Healthcare

Dr Matthew Fenech

Medical Safety Lead - Ada Health

Sylvia Kim

Managing Director - Koa Venture Fund
12:00 - 12:10

Robotics in the operating theatreAn overview of the successful applications of robotic surgery.

Daniel Teo

Managing Partner - Hunniwell Lake Ventures
12:10 - 12:25

Smart Implants The future of smart implants in orthopedic surgery.

Prof Pierre Schembri-Wismayer MD PhD

Associate Professor - Anatomy Department, University of Malta

Ing Donald Dalli

PhD Student - MALTAHIP project, University of Malta

Jeremy Micallef

Reporter - SiGMA
12:25 - 12:35

Origami Engineering for the Brain Saving lives curing brain aneurysms.

Mike Karim

CEO - Oxford Endovascular Ltd
12:35 - 13:00

Automation in Catheter ManufacturingAn examination at the feasibility, challenges and considerations to automating a catheter manufacturing process. An overview from production design to mass production looking at assembly, inspection, repeatability, validation and manufacturing technology.

Bryan Mathias

Director of Business Development - SYNEO

Dmitrij Velikan

Director of Sales EMEA - machinesolutions

DIGITISED HEALTHCARE

13:15 - 13:35

Changing Public Perception to Allow Digital Health Ecosystems to Flourish The COVID-19 Pandemic was an interesting opportunity to look into how the Public embraced a shift towards digital health and med tech to solve their healthcare challenges. Public Health and Digital Health played an important role in enabling this shift. This panel will look into what happened to enable this and how the future of Digital Health ecosystems will evolve with the active participation of Public Health and Healthcare Organizations.

Dr Ryan Grech

Co-Founder - Digital Health Malta

Prof Charmaine Gauci

Superintendent of Public Health, Ministry for Health; Associate Professor, University of Malta

Dr Dylan Attard

Co-Founder - Digital Health Malta

Dr Stefan Buttigieg

Co-Founder - Digital Health Malta
13:35 - 13:45

Digital Health mobile Ambiguous advice, questionable quality: Determining, evaluating and distributing quality Health Apps.

Liz Ashall-Payne

CEO - ORCHA
13:45 - 14:10

Cybersecurity The more technology becomes a part of healthcare infrastructure how are hacks to be avoided?

Dr. Gege Gatt

CEO - EBO

Daniel Torres Gonçalves

Managing Partner - K.LEX

Elliot Turrini

CEO - Practical Cyber

Alan Platt

COO - CyberHive
14:10 - 14:20

The Use of A.I. and Patient confidentiality What are the challenges between the use of A.I., patient confidentiality and the GDPR/data protection law?

Thanos Rammos

Attorney and Partner / Specialist Lawyer for IT Law - Taylor Wessing

INVESTMENTS IN MEDTECH WORLD

14:20 - 14:45

The Struggles of Early-Stage MedTech Startups Building startup teams and issues to consider. Lifecycle of a medtech startup and the operational challenges and how to approach investors and the challenges of early-stage fundraising.

Aaron Green

Managing Partner - Iridium Enterprises, LLC

Giovanni Lauricella

Vice President, MedTech - The Mullings Group

Nikhil Sadhwani

Managing Partner - Kaviar Consulting, LLC
14:45 - 15:00

Human Resource Management during Covid-19 Why Medical Device Companies Need to Compete Even Harder For To Hire and Retain Talent During The Covid-19 Crisis.

Nigel Job

CEO - Remtec Talent Management Ltd
15:00 - 15:25

The Process and Challenges of raising Capital for Early-Stage MedTech Startups Raising capital for early-stage MedTech startups is difficult. We will explore how and where to start a fundraising process, the major challenges that arise, and share insights on how to make raising capital more efficient for MedTech entrepreneurs.

Giovanni Lauricella

Vice President, MedTech - The Mullings Group

Dr. Simon J. Sonntag

CEO&Co-Founder - Virtonomy

Jeff Rynbrandt

President and CEO - MediCool Technologies, Inc.
15:25 - 15:35

The Growing Chinese MedTech Market China is increasingly challenging Western medical technology companies. Asia, including China, will be one of the most important markets for MedTech companies in the future. This is not only due to rising numbers of elderly people but also due to favorable politics in regards to MedTech.

Mareike Seesselberg

Senior Consultant - CHINABRAND IP CONSULTING GmbH
15:35 - 16:00

Entrepreneurship, Technology and Innovation in MedTech Creating a sustainable future for MedTech requires a robust med tech and digital health ecosystem that fully involves all the relevant stakeholders. Enabling Entrepreneurship, Technology and Innovation requires an all hands onboard approach from everyone and setting up the right knowledge transfer to enable a positive cycle that brings growth whilst maintaining a robust and high-quality evidence base.

Dr Stefan Buttigieg

Co-Founder - Digital Health Malta

Prof. Russell Smith

Director of the Centre for Entrepreneurship and Business Incubation - University of Malta

Dr. Conrad Attard

Deputy Dean Faculty of ICT, Researcher, and Lecturer - University of Malta; Chair - IEEE Malta

Prof Philip Farrugia

Associate Professor - University of Malta

FUTURE TRENDS

16:00 - 16:20

VRx: How Virtual Therapeutics Will Revolutionize Medicine In this talk, we will explore how VR can modify our reality in ways that may be hard to accomplish in times of vulnerability and distress. VR does this by radically changing our perspective of the world.

Brennan Spiegel, MD, MSHS

Professor of Medicine and Public Health - Cedars-Sinai
16:20 - 16:30

Virtual Reality: a digital health tool to improve patients' therapy experienceWhen patients are forced to undergo stressful medical procedures and long term hospitalization, how is it possible to provide a better therapy experience?

Valentino Megale, Ph.D.

CEO - Softcare Studios
16:30 - 16:50

The Medicine of Things The healthcare industry has been slow to adapt to new technologies though in recent months the digital growth has been accelerated. The Internet of Medical Things (IoMT) is set to transform how we can keep people safe and healthy. The cost of healthcare is ever increasing and therefore the demand for solutions that offer lower cost with maximal efficiency is on the rise.

Dr Ryan Grech

Co-Founder - Digital Health Malta

Dr Deo Falzon

Associate - Fenech & Fenech Advocates

Kenneth Terribile

Senior Technical Sales Engineer - Melita
16:50 - 17:00

It's a matter of life and (Sex)Tech Time for sexual health to break out of the medical chamber. How innovation doesn’t stop in the lab and the conversation in sexual health should follow the road to behavioural change?

Dominnique Karetsos

CEO & Co-founder - The Healthy Pleasure Group